Total Payments
$17,384
2024 Payments
$1,581
Companies
56
Transactions
925
Medicare Patients
4,095
Medicare Billing
$456,862
Payment Breakdown by Category
Food & Beverage$16,172 (93.0%)
Consulting$1,200 (6.9%)
Education$12.02 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,172 | 922 | 93.0% |
| Consulting Fee | $1,200 | 1 | 6.9% |
| Education | $12.02 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,244 | 128 | $0 (2024) |
| Novo Nordisk Inc | $2,704 | 161 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,490 | 7 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $1,223 | 78 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $884.18 | 43 | $0 (2024) |
| GlaxoSmithKline, LLC. | $881.43 | 60 | $0 (2024) |
| PFIZER INC. | $720.80 | 57 | $0 (2024) |
| Astellas Pharma US Inc | $643.02 | 41 | $0 (2024) |
| Abbott Laboratories | $639.06 | 17 | $0 (2024) |
| Amgen Inc. | $620.07 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,581 | 78 | Novo Nordisk Inc ($325.67) |
| 2023 | $1,959 | 106 | Abbott Laboratories ($322.56) |
| 2022 | $1,679 | 93 | Janssen Pharmaceuticals, Inc ($282.31) |
| 2021 | $3,748 | 113 | Biohaven Pharmaceuticals, Inc. ($1,490) |
| 2020 | $1,340 | 76 | AstraZeneca Pharmaceuticals LP ($727.04) |
| 2019 | $2,744 | 147 | AstraZeneca Pharmaceuticals LP ($830.99) |
| 2018 | $2,388 | 164 | AstraZeneca Pharmaceuticals LP ($602.17) |
| 2017 | $1,946 | 148 | AstraZeneca Pharmaceuticals LP ($487.08) |
All Payment Transactions
925 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $140.16 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Gastroenterology | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.24 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: PAIN | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $120.38 | General |
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.83 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $13.13 | General |
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $14.01 | General |
| 09/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Biological | ||||||
| 09/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Bone Health | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 997 | 1,936 | $270,443 | $135,513 |
| 2022 | 21 | 1,048 | 1,594 | $231,849 | $116,036 |
| 2021 | 20 | 964 | 1,428 | $196,094 | $110,649 |
| 2020 | 20 | 1,086 | 1,571 | $193,257 | $94,664 |
Total Patients
4,095
Total Services
6,529
Medicare Billing
$456,862
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 243 | 551 | $110,200 | $48,663 | 44.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 153 | 153 | $31,212 | $20,242 | 64.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 41 | 312 | $29,328 | $15,211 | 51.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 170 | $24,140 | $9,947 | 41.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 35 | 75 | $12,150 | $7,348 | 60.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 26 | 143 | $10,439 | $5,545 | 53.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 36 | $10,116 | $4,827 | 47.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 49 | 49 | $5,540 | $3,644 | 65.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 19 | 79 | $5,925 | $3,144 | 53.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $4,714 | $3,112 | 66.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $6,300 | $2,856 | 45.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $4,774 | $2,503 | 52.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 30 | $3,390 | $1,954 | 57.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $3,915 | $1,877 | 48.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 53 | 53 | $2,385 | $1,628 | 68.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 11 | 36 | $1,946 | $1,021 | 52.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 73 | $1,460 | $686.77 | 47.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $598.00 | $406.64 | 68.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 39 | 39 | $897.00 | $345.25 | 38.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 23 | $506.00 | $255.64 | 50.5% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 12 | 12 | $348.00 | $189.12 | 54.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 30 | 32 | $160.00 | $109.12 | 68.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 261 | 602 | $120,915 | $53,336 | 44.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 132 | 132 | $24,278 | $18,028 | 74.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 156 | 218 | $30,956 | $14,650 | 47.3% |
About Dr. Moo Chung, M.D
Dr. Moo Chung, M.D is a Internal Medicine healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306846977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Moo Chung, M.D has received a total of $17,384 in payments from pharmaceutical and medical device companies, with $1,581 received in 2024. These payments were reported across 925 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($16,172).
As a Medicare-enrolled provider, Chung has provided services to 4,095 Medicare beneficiaries, totaling 6,529 services with total Medicare billing of $456,862. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Katy, TX
- Active Since 07/26/2005
- Last Updated 12/17/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1306846977
Products in Payments
- FARXIGA (Drug) $2,795
- NURTEC ODT (Drug) $1,630
- XARELTO (Drug) $1,064
- Ozempic (Drug) $867.62
- JARDIANCE (Drug) $753.13
- TRELEGY ELLIPTA (Drug) $459.04
- XIFAXAN (Drug) $451.71
- FREESTYLE LIBRE 3 (Device) $413.91
- MYRBETRIQ (Drug) $362.93
- RYBELSUS (Drug) $338.64
- Victoza (Drug) $288.00
- ENTRESTO (Drug) $280.83
- Kerendia (Drug) $278.79
- Saxenda (Drug) $278.58
- Tresiba (Drug) $274.83
- TOUJEO (Drug) $268.11
- Otezla (Drug) $263.45
- Rybelsus (Drug) $246.06
- GEMTESA (Drug) $237.44
- Wegovy (Drug) $230.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Katy
Dharmendra Verma, M.d, M.D
Internal Medicine — Payments: $43,959
Internal Medicine $43,959
Dr. Syed Zaidi, M.d, M.D
Internal Medicine — Payments: $20,985
Internal Medicine $20,985
Dr. Mukesh Mehta, M.d, M.D
Internal Medicine — Payments: $18,042
Internal Medicine $18,042
Roger Campana, Md, MD
Internal Medicine — Payments: $17,323
Internal Medicine $17,323
Mr. Barry Troyan, Md, MD
Internal Medicine — Payments: $16,038
Internal Medicine $16,038
Viswanath Kalapatapu, M.d, M.D
Internal Medicine — Payments: $14,406
Internal Medicine $14,406